SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027314
Filing Date
2016-11-03
Accepted
2016-11-03 15:29:09
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20160930.htm 10-Q 1163494
2 EX-31.1 snss-ex311_358.htm EX-31.1 16178
3 EX-31.2 snss-ex312_357.htm EX-31.2 16726
4 EX-32.1 snss-ex321_356.htm EX-32.1 8192
5 GRAPHIC g2016110316534395412259.jpg GRAPHIC 3336
  Complete submission text file 0001564590-16-027314.txt   4028890

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20160930.xml EX-101.INS 776091
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20160930.xsd EX-101.SCH 37073
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20160930_cal.xml EX-101.CAL 37925
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20160930_def.xml EX-101.DEF 99708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20160930_lab.xml EX-101.LAB 266856
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20160930_pre.xml EX-101.PRE 182321
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 161971368
SIC: 2834 Pharmaceutical Preparations